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“We must use the right kind of fluid in appropriate amounts at the right time.”  
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APCO arterial pressure waveform analysis 
BMI body mass index 
CBF cerebral blood flow 
CI cardiac index 
CO cardiac output 
CPP cerebral perfusion pressure  
CT  clotting time  
CFT clot formation time 
DD delta down 
DPP delta pulse pressure 
ECG electrocardiography 
ETCO2 end-tidal concentration of carbon dioxide 
GDT goal-directed therapy 
HES hydroxyethyl starch 
Hb  haemoglobin concentration   
Hct  haematocrit value  
HR heart rate 
ICP intracranial pressure 
INR International Normalized Ratio  
LR lactated Ringer´s 
MAC mimimal alveolar concentration  
MAP mean arterial pressure  
MCF maximum clot firmness 
NS non-significant 
PaCO2 arterial carbon dioxide tension 
PEEP positive end-expiratory pressure 
Plt  platelet count  
PPV pulse pressure variation 
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QALYs quality-adjusted life years 
RAC Ringer´s acetate 
ROTEM rotational thromboelastometry 
SAH subarachnoid haemorrhage 
SAP systolic arterial pressure 
SEM standard error of the mean 
SD standard deviation 
SpO2 arterial saturation of oxygen 
SPV systolic pressure variation 
SV stroke volume 
SVI stroke volume index 
SVV stroke volume variation 
TEG thromboelastography 






















The major aims with fluid therapy for neurosurgical procedures are to minimize the risk for inadequate cerebral 
perfusion pressure (CPP) and to maintain good neurosurgical conditions. Excessive fluid restriction to minimize 
cerebral oedema may lead to haemodynamic instability. Patient positioning, especially sitting and prone 
positions, may also promote haemodynamic changes due to venous pooling and diminished venous return to the 
heart. The effect of fluid therapy on coagulation must be considered, because normal coagulation capacity is of 
particular importance in neurosurgery to prevent bleeding complications.  
 
Patients and methods 
This thesis examined the effects of fluid therapy on haemodynamic parameters and coagulation in neurosurgery. 
The complications of the sitting position were analyzed in a retrospective study. Stroke volume (SV)-directed 
administration of fluids during neurosurgery in the sitting and the prone position and the effect of a totally 
balanced fluid concept, and mannitol, on blood coagulation in vitro was examined.  
 
The haemodynamic profile of 72 patients treated for pineal-region tumours in the sitting position were 
retrospectively evaluated (Study I). Other studies involved 60 adult patients scheduled for elective primary 
neurosurgery (Studies II and III) and 22 healthy volunteers (Studies IV and V). 
 
 Patients were randomized to receive either hydroxyethyl starch (HES) 130/0.4 or Ringer´s acetate (RAC) 
according to SV-directed administration of fluids, in addition to a basal infusion of 3 mL/kg/h RAC. Before 
sitting (Study II, n=30) or prone (Study III, n=30) position SV, measured by arterial pressure waveform analysis, 
was maximized by boluses of study fluid until no increase occurred of more than 10%. SV was maintained by 
repeated administration of boluses of study fluid during surgery. The volumes of HES and RAC required for 
stable haemodynamics were compared.  
 
Venous blood collected from 12 healthy volunteers (Study IV) was diluted to 20% and 40% with a combination 
of an equal amount of colloid (balanced or unbalanced HES 130/0.4 or gelatin) and crystalloid (balanced or 
unbalanced RAC) in vitro. Venous blood collected from ten healthy volunteers (Study V) was diluted to 10% 
10 
 
and 20% with mannitol alone, mannitol and RAC, and mannitol and HES 130/0.4 in vitro.  Blood samples were 
analyzed with rotational thromboelastometry (ROTEM®). 
 
Results  
The sitting position is associated with hypotension and a risk for venous air embolism (VAE) (Study I). We 
found an intraoperative crystalloid vs. colloid volume ratio of 1.5 (Studies II, III). In Study III, the formation and 
maximum strength of the fibrin clot were decreased after an average dose of 440 mL of HES 130/0.4. In Study II, 
an average dose of 460 mL of HES 130/0.4 did not impair the coagulation profile in thromboelastometry. No 
difference appeared in blood loss between the groups in either study. The combination of balanced colloid and 
crystalloid had similar coagulation effects in vitro as did their respective combinations of unbalanced solutions 
(Study IV). We found that mannitol alone and in combination with HES 130/0.4 delayed the initiation of 
coagulation and fibrin formation and reduced the maximum clot firmness in vitro (Study V).   
 
Conclusions 
The sitting position induces hypotension and carries a risk for VAE. SV-directed administration of either 
crystalloid or colloid stabilizes the haemodynamic parameters in the sitting and prone position. Most of the 
patients undergoing neurosurgery in either position can be managed with an acceptable volume of RAC. A 
crystalloid vs. colloid ratio of 1.5 intraoperatively is lower than expected, taking into account the haemodynamic 
changes induced by the position. The haemodynamic response of goal-directed HES administration was more 
favourable with regard to cardiac index (CI), and a bolus of HES (<500mL) may be administered when instant 
restoration of the intravascular volume with minimal fluid loading is indicated. The effect of fluid therapy with 
HES on coagulation measured in the studies with thromboelastometry varied. The intraoperative blood loss in 
these patients was very low; the clinical relevance of the findings remains unclear.  No advantage with the totally 
balanced fluid therapy for coagulation emerged. Mannitol alone or in combination with HES 130/0.4 impairs clot 















Den främsta målsättningen med vätsketerapi för neurokirurgiska patienter är att minimera risken för otillräckligt 
blodflöde till hjärnan och samtidigt upprätthålla goda operationsförhållanden för neurokirurgen. Överdriven 
restriktion av vätsketillförseln för att minimera hjärnsvullnad kan leda till instabil hemodynamik. Placeringen av 
patienten under operationen, speciellt i sittande eller magläge, kan också förorsaka hemodynamisk instabilitet på 
grund av ansamling av blod i venerna och minskat tillbakaflöde till hjärtat. Effekten av vätsketerapi på blodets 
koagulation måste beaktas, emedan normal koagulation är av speciell vikt inom neurokirurgin för att undvika 
blödningskomplikationer.  
 
Patienter och metoder 
I denna avhandling granskas vätsketerapins effekter på hemodynamik samt koagulation inom neurokirurgin. 
Komplikationerna associerade med sittande läge analyserades retrospektivt. Slagvolym-styrd administration av 
vätskor under neurokirurgi i sittande och magläge, samt effekten av balanserade vätskor och mannitol på blodets 
koagulering in vitro undersöktes. 
 
Hemodynamiken hos 72 patienter opererade för tumör i området kring epifysen i sittande läge utvärderades 
retrospektivt (Studie I). De övriga studierna omfattade 60 vuxna, elektiva neurokirurgiska patienter (Studie II 
och III) och 22 friska frivilliga (Studie IV och V). 
 
Patienterna randomiserades att få antingen hydroxyetylstärkelse (HES) 130/0.4 eller Ringer´s acetat (RAC) i 
enlighet med slagvolym-styrd administration av vätskor utöver en infusion av 3 mL/kg/h RAC. Slagvolymen, 
uppmätt med hjälp av analys av artärkurvan, maximerades före sittande (Studie II, n=30) eller magläge (Studie 
III, n=30) med hjälp av bolusdoser av vätska tills slagvolymen inte ökade med mer än 10 %. Slagvolymen 
upprätthölls på denna nivå med hjälp av upprepade bolusdoser av vätska under operationen. Volymerna av HES 
och RAC som behövdes för en stabil hemodynamik jämfördes.  
 
Venöst blod från tolv friska frivilliga (Studie IV) späddes ut till 20 % och 40 % med en kombination av lika 
delar kolloid (balanserad eller icke balanserad HES 130/0.4 eller gelatin) och krystalloid (balanserad eller icke 
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balansed RAC) in vitro. Venöst blod från tio friska frivilliga (Studie V) späddes ut till 10 % och 20 % med 
mannitol, en kombination av mannitol och RAC, och en kombination av mannitol och HES 130/0.4 in vitro.  
Blodproverna analyserades med tromboelastometri (ROTEM®). 
 
Resultat 
Sittande läge under operationen innebär en risk för hypotension samt venös luftemboli (VAE) (Studie I). I våra 
studier fann vi ett 1,5:1 förhållande i vätskevolym intraoperativt angående krystalloid jämfört med kolloid 
(Studier II, III). I Studie III minskade bildandet och den maximala styrkan hos fibrinnätet efter en medeldos av 
440 ml med HES 130/0.4. I Studie II försämrade inte en medeldos på 460 ml HES 130/0.4 koagulationen mätt 
med tromboelastometri. Det förekom inga skillnader i blodförlust mellan grupperna i någondera studien. 
Kombinationen av balanserad kolloid och krystalloid hade liknande effekter in vitro på koagulationen som 
respektive kombination av icke balanserade vätskor (Studie IV). Mannitol ensamt och i kombination med HES 
130/0.4 fördröjde initieringen av koagulationen och fibrinets bildande samt minskade den maximala styrkan av 
blodkoaglet in vitro (Studie V).   
 
Konklusioner 
Sittande ställning förorsakar hypotension och innebär en risk för venös luftemboli. Slagvolym-styrd 
administration av antingen krystalloid eller kolloid stabiliserar hemodynamiken i sittande och magläge. De flesta 
neurokirurgiska patienter som opereras i endera ställningen kan skötas med enbart RAC i moderata volymer. Ett 
krystalloid vs. kolloid förhållande av 1.5:1 intraoperativt är lägre än förväntat med beaktande av den påverkan 
patientens ställning har på hemodynamiken. Det  hemodynamiska gensvaret av målstyrd HES administration var 
bättre med tanke på  hjärtindex (cardiac index ,CI), och en bolus med HES (<500ml) kan ges när omedelbar 
återupprättande av intravaskulära volymen med minimal vätskebelastning är indicerad. Effekten av vätsketerapi 
med HES på koagulationen mätt med hjälp av tromboelastometri varierade. Intraoperativa blodförlusten hos 
dessa patienter var låg och den kliniska betydelsen av våra fynd förblir oklar. Det framkom inga fördelar med 
fullständigt balanserad vätskebehandling. Mannitol ensam och i kombination med HES 130/0.4 försämrar 









Nestehoidon päätavoitteet neurokirurgisen leikkauksen aikana on ylläpitää riittävä aivojen perfuusiopaine ja 
hyvät leikkausolosuhteet. Liian vähäinen nestehoito, aivoturvotuksen vähentämiseksi, voi johtaa epävakaaseen 
verenkiertoon. Anestesia erityisesti istuvassa- tai vatsa-asennossa voi heikentää verenkiertoa ja sydämen 
minuuttivirtausta, koska laskimoveri kerääntyy alaraajoihin ja sen paluu sydämeen heikkenee. Lisäksi 
nestehoidon mahdolliset vaikutukset veren hyytymiseen tulee huomioida, koska normaali hyytyminen on 
erityisen tärkeää neurokirurgiassa vuotokomplikaatioiden estämiseksi. 
 
Potilaat ja menetelmät 
Tämä väitöskirja selvittää neurokirurgian aikaisen nestehoidon vaikutuksia verenkiertoon ja sydämen toimintaan 
sekä veren hyytymiseen. Istuvan asennon sivuvaikutuksia tutkittiin aluksi retrospektiivisesti. Sydämen 
iskutilavuuden ohjaamaa nestehoitoa tutkittiin istuvassa asennossa ja vatsa-asennossa tehtävien neurokirurgisten 
toimenpiteiden aikana. Täysin balansoitujien liuosten ja mannitolin vaikutuksia veren hyytymiseen selvitettiin 
kokeellisesti in vitro. 
 
72 istuvassa asennossa, pineaalituumorin takia leikatun potilaan hemodynaaminen profiili analysoitiin 
retrospektiivisesti (Tutkimus I). Muihin tutkimuksiin rekrytoitiin 60 elektiiviseen neurokirurgiseen toi-
menpiteeseen tulevaa aikuispotilasta (Tutkimukset II ja III) ja 22 tervettä, vapaaehtoista aikuista (Tutkimukset 
IV ja V). 
 
Potilaat satunnaistettiin saamaan tausta-infuusiona toimineen Ringerin asetaattiliuoksen (3ml/kg/h) rinnalla 
iskutilavuuden mukaan ohjattua nestehoitoa, joko HES-liuosta (molekyylipaino 130/0.4) tai Ringerin liuosta 
(RAC) käyttäen. Ennen siirtymistä istuvaan asentoon (Tutkimus II, n=30) tai vatsa-asentoon (Tutkimus III, n=30) 
valtimopaineen paineaallon muotoon perustuvan analyysin avulla mitattu iskutilavuus maksimoitiin 
nesteboluksilla, kunnes se ei enää suurentunut yli 10 % edelliseen mittaukseen verrattuna. Iskutilavuus 
ylläpidettiin leikkauksenaikaisilla nesteboluksilla ja vakaaseen hemodynamiikkaan tarvittuja määriä HES- ja 




12 terveeltä vapaaehtoiselta otettu laskimoverinäyte (Tutkimus IV) laimennettiin in vitro 20 ja 40 prosentin 
tilavuusvahvuuteen käyttäen yhtä suurista annoksista kolloidia (balansoitu tai ei-balansoitu HES 130/0.4 tai 
gelatiini) ja kristalloidia (balansoitu tai ei-balansoitu RAC) valmistettua liuosta. 10 terveeltä vapaaehtoiselta 
otettu laskimoverinäyte (Tutkimus V) laimennettiin in vitro 10 ja 20 prosentin tilavuusvahvuuteen käyttäen 
pelkkää mannitolia tai mannitolin ja RAC sekoitusta, tai mannitolia ja HES 130/0.4 sekoitusta. Verinäytteet 
analysoitiin tromboelastometrillä (ROTEM®). 
 
Tulokset 
Istuvaan asentoon yleisanestesiassa liittyy hypotension ja laskimoperäisen ilmaembolian riski (VAE). (Tutkimus 
I). Tutkimuksissamme leikkauksen aikana annetun kristalloidin ja kolloidin välinen tilavuussuhde oli 1,5:1 
(Tutkimukset II, III). Tutkimuksessa III fibriiniverkon muodostuminen ja maksimivahvuus väheni 
keskimääräisesti 440ml HES 130/0.4-annoksen jälkeen. Tutkimuksessa II keskimääräinen annos 460ml HES 
130.04 ei häirinnyt tromboelastometrilla mitattua hyytymisprofiilia. Kummassakaan tutkimuksessa ei tullut esiin 
ryhmien välistä eroa verenhukan suhteen. Balansoiduilla kristalloideilla ja kolloideilla oli in vitro samantapaiset 
hyytymisvaikutukset kuin vastaavien liuosten balansoimattomilla sekoituksilla (Tutkimus IV). Kokeellisessa 
tutkimuksessa mannitoli yksinään ja yhdessä HES 130/0.4 kanssa viivästytti hyytymisen ja fibriinin-
muodostuksen alkua sekä vähensi hyytymän maksimilujuutta in vitro (Tutkimus V). 
 
Päätelmät 
Istuva asento altistaa hypotensiolle ja ilmaembolialle. Sydämen iskutilavuuden ohjaama kristalloidin tai 
kolloidin anto tasoittaa hemodynaamisia parametreja istuvassa- ja vatsa-asennossa. Suurin osa istuvassa- tai 
vatsa-asennossa leikattavista neurokirurgisista potilaista voidaan hoitaa hyväksyttävällä määrällä RAC-liuosta. 
Kristalloidin ja kolloidin leikkauksen aikainen tilavuussuhde oli 1,5:1. Tämä on vähäisempi kuin odotettu, 
varsinkin kun huomioidaan asennon aiheuttamat hemodynaamiset vaihtelut. Tavoite-ohjattu HES-liuoksen anto 
oli suotuisaa ajatellen sydämen minuuttivirtausta (cardiac index, CI). HES-bolus (<500ml) voidaan antaa kun 
välitön suonensisäisen tilavuuden korjaus mahdollisimman pienellä nestemäärällä on aiheellista. 
Tromboelastometrilla analysoidun, HES-liuoksella toteutetun nestehoidon vaikutus hyytymiseen vaihteli 
tutkimuksissa. Koska potilaiden leikkauksen jälkeinen verenhukka oli hyvin vähäinen, tämän löydöksen 
kliininen merkitys jää epäselväksi. Täysin balansoidut liuokset aiheuttivat myös hyytymishäiriön, eikä se eronnut 
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ei-balansoiduista liuoksista.  Mannitoli yksinään tai yhdessä HES 130/0.4 kanssa häiritsee hyytymän 































Haemodynamic stability and adequate cerebral perfusion pressure (CPP) are of the utmost importance in 
neuroanaesthesia.1 Anaesthesia in the sitting and prone position is associated with a significant risk for 
hypotension 2,3 and decreased cardiac output (CO),4, 5  which may jeopardize cerebral perfusion, especially if 
cerebral blood flow (CBF) autoregulation is disturbed. During craniotomy in the sitting position venous pooling 
of blood into lower extremities,6 venous air embolism (VAE), 7 or cranial nerve manipulation 8 further 
aggravates haemodynamic instability.  
 
Fluid management for neurosurgical patients involves several special features and controversies. The patient´s 
hydration and volume status before the neurosurgery may be affected by emesis, sweating, or fever. Potent 
diuretics such as mannitol in treatment of intracranial hypertension,9 intraoperative bleeding, and the possibility 
of diabetes insipidus10, 11 may all affect intravascular volume. Patient positioning during surgery also promotes 
haemodynamic changes.12,13,14  To preserve adequate cerebral perfusion pressure without causing brain oedema 
requires preload conditions to be optimal.  
 
Choice of fluid, amount of fluid, and means to monitor the effect of fluid therapy in surgical patients have all 
been debated for a long time. Several studies have shown the effect of fluid therapy on post-operative outcome.15 
Improved outcome has been demonstrated with goal-directed therapy (GDT) to optimize haemodynamic 
parameters.16 Compared with traditional fluid treatment, GDT has also been suggested to lower costs of medical 
care as well as gain quality-adjusted life years (QALYs).17 
 
Movement of water across the intact blood-brain barrier depends primarily on the osmotic gradient between 
plasma and the brain; osmolarity is therefore a very important property of a solution.18 Crystalloids (e.g. Ringer´s 
acetate (RAC) or normal saline) are administered as maintenance fluid intraoperatively, to cover the basal fluid 
requirements and may be hypo-osmolar, iso-osmolar, or hyperosmolar.  Hyperosmolar fluids (e.g. mannitol or 
hypertonic saline) lower intracranial pressure (ICP).19, 20 Colloids (albumin, dextran, gelatine, hydroxyethyl 
starch (HES) solutions) are efficient plasma expanders administered to restore and maintain intravascular 




In neurosurgery, normal coagulation capacity is of particular importance to minimize the risk for bleeding 
complications.22 Colloids may affect coagulation beyond haemodilution, and HES solutions in particular have 
been reported to impair coagulation.23 An HES-induced coagulation disturbance is dose-dependent, 24 and 
modern, rapidly degradable HES solutions (e.g. HES 130/0.4) have been considered safer.25, 26 HES 130/0.4 has 
been used in neurosurgery during brain tumour resection.27  
  
The objective of this thesis was to characterize the haemodynamic effects of positioning during goal-directed 
therapy with a crystalloid or a colloid in neurosurgical patients undergoing surgery in the sitting and prone 









































REVIEW OF THE LITERATURE 
 
  
PATIENT POSITIONING IN NEUROSURGERY 
 
 
The sitting position (Figure 1) provides optimal access to intracranial posterior midline lesions and has served 
for posterior fossa, as well as cervical spine surgery.4 Because of its potential for serious complications, use in 
cervical spine surgery has, however, declined; neurosurgical centres using the sitting position for posterior fossa 
surgery are also diminishing.4 Although this position does improve cerebral venous drainage, lower intracranial 
pressure, and promote gravity drainage of blood and cerebral spinal fluid from the surgical field, 4 possible 
complications related to the sitting position include haemodynamic instability, VAE, pneumocephalus, 
quadriplegia, and compressive peripheral neuropathy.4 General anaesthesia in the sitting position is associated 
with hypotension; CO can decrease by 10 to 20%.4 Possible mechanisms are venous pooling in the lower 
extremities and redistribution of blood volume from the intra- to the extrathoracic compartment.2 VAE can occur 
in any position with a negative pressure gradient between the surgical site and the right atrium, and VAE has 
occurred although not so frequently during neurosurgery in the lateral, supine, or prone positions as well. 28,29 
 
 
Figure 1. Sitting position. From the book by M Lehecka, A Laakso, J Hernesniemi. Helsinki Microneurosurgery  
Basics and Tricks, 2011. Printed with the kind permission of the authors.  
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The prone position (Figure 2)  provides surgical access to the posterior head, neck, and spinal column and is used 
for spinal surgery as well as parietal, occipital, and suboccipital craniotomies.28 General anaesthesia in the prone 
position is associated with hypotension,30 and CO has been reported to decrease 17 to 24%.5 Possible 
mechanisms behind the CO reduction are reduced venous return, direct effects on arterial filling, and reduced left 
ventricular compliance secondary to increased thoracic pressure.5 Abdominal compression causing obstruction 
of the inferior vena cava reduces CO further and also promotes blood loss during spinal surgery due to increased 
filling of the vertebral column veins.5 Further complications associated with neurosurgery in the prone position 
are cervical spine injury, spinal cord ischaemia, pneumocephalus, peripheral nerve injury, postoperative visual 




Figure 2. Prone position. From the book by M Lehecka, A Laakso, J Hernesniemi. Helsinki Microneurosurgery 










PERIOPERATIVE FLUID MANAGEMENT 
 
 
Perioperative fluid therapy is part of almost all surgical procedures, and although an everyday issue is still 
controversial. This practice has varied from `liberal´ to `restrictive´. The principles of a restricted fluid regimen 
were introduced as early as in the late 1950s by Francis Moore. In the 1960s Tom Shires came up with the 
concept of `third space losses´ due to redistribution of fluids during surgery; he also postulated replacement of 
these losses.31 Later, the existence of this `third space´ has been questioned,32 and excess fluid replacement is 
suggested to accumulate interstitially.33 With no established definition of `liberal´ and `restrictive´ fluid therapy 
and inconsistent study designs, a comparison of the two different fluid regimen is difficult.15 Most of the studies 
regarding `restrictive´ fluid therapy include only abdominal surgery with high-risk patients excluded, and the 
results can therefore not be directly applied to all surgical patients.15    
 
Normovolaemia is a widely accepted goal for fluid therapy in neurosurgical patients, although perioperative fluid 
therapy in these patients has been scarcely investigated. Stroke volume variation (SVV) as well as delta pulse 
pressure (DPP) and delta down (DD), derived from the variation in arterial pressure associated with mechanical 
ventilation, has predicted fluid responsiveness accurately in neurosurgical patients.34, 35  According to a study in 
subaracnoid haemorrhage patients (SAH), comparing APCO with a pulmonary artery catheter, the second 
generation of the FloTrac®/Vigileo® monitoring system underestimates CO values.36 In another study 
comparing uncalibrated APCO to transpulmonary thermodilution (PiCCO) for GDT after SAH, the third-
generation FloTrac®/Vigileo®  still underestimates CI during hyperdynamic therapy with dobutamine, but it 
may be acceptable to measure trends of CI.37 In patients undergoing elective brain surgery, however, SVV 
obtained by the third-generation FloTrac®/Vigileo® is a sensitive predictor of fluid responsiveness.38    
 
The stress induced by surgery causes release of stress hormones reducing the excretion of salt and water during 
surgery.39 Anaesthetics per se are not associated with extravascular retention of fluids in surgical patients, but 
anaesthesia-related hypotension affects the kinetic behaviour of fluids.40 In the absence of surgical stress, 
isoflurane anaesthesia in volunteers altered the disposition of fluids, because of reduced clearance and a slower 
distribution, with approximately 10% more of the fluid bolus accumulated in the peripheral compartment.41 Fluid 
loading has minimal influence on anaesthesia-related hypotension,41 and this should preferably be treated with 
vasopressor therapy.42 Serum colloid osmotic pressure falls in response to surgery,43 and this affects 
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intravascular volume. After major surgery, endothelial glycocalix changes occurs similar to those in sepsis, but 
to a lesser extent; this may cause a non-specific capillary leak syndrome.44  
 
The aim of perioperative fluid therapy is to maintain the circulating plasma volume and thus ensure organ 
perfusion and oxygen delivery to the tissues.45 This has traditionally been achieved by infusion of large volumes 
of fluids,45 resulting in a positive intraoperative fluid balance, which can, however, be associated with significant 
morbidity postoperatively.46 Generally fluid therapy includes replacement of basal fluid requirements and fluid 
losses such as by perspiration, blood loss, and exudation through the surgical wound; as well as maintenance of 
physiological functions to avoid hypotension.39 
 
Perioperative hypovolemia induces hypotension and may cause organ dysfunction, increased post-operative 
morbidity, and death.47 Excess fluid replacement, on the other hand, leads to increased demands on cardiac and 
kidney function and may cause pulmonary, intestinal, and subcutaneous oedema with impaired oxygen diffusion 
to the tissues.48 GDT in the perioperative period reduces surgical complications and also improves long-term 
survival. 16, 49,50 Perioperative GDT reduces surgical site infections, pneumonia, and urinary tract infections, 51 as 
well as gastrointestinal complications.52 Compared to conventional fluid therapy, perioperative GDT also 
reduces the incidence of acute kidney injury,53 mainly by minimizing the harmful effects of fluid overload.54 Not 
all studies of GDT report positive results, however; one study of GDT in open elective abdominal aortic surgery 
reports no effect on the incidence of post-operative complications,55 and GDT for vascular surgery patients did 
not result in higher tissue oxygen delivery.56 Tissue perfusion monitoring remains controversial; the ideal marker 
of tissue perfusion is still lacking.50 Concern has arisen that most of the studies about GDT are single-centre 
trials and underpowered to detect a difference in mortality.57 
  
The concept of fluid resuscitation aiming for supra-normal haemodynamic parameters was introduced by 
Shoemaker in the 1970s and 1980s.58 At the start, GDT required use of the invasive technique of a pulmonary 
artery catheter for haemodynamic monitoring.59 Minimally invasive haemodynamic monitoring including 
oesophageal Doppler and APCO such as by SVV and pulse pressure variation (PPV) have been developed in 
recent years. According to one systematic review, both morbidity and mortality were reduced with use of the 
newer generation of monitoring as well as with the pulmonary artery catheter for pre-emptive haemodynamic 
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monitoring.16  In a meta-analysis, all forms of haemodynamic monitoring for GDT appeared to be equally 
effective in reducing perioperative complications.60    
 
Individualized GDT is based on the physiological principle of the Frank-Starling law of the heart, with a 
curvilinear relationship between ventricular preload and ventricular stroke volume (Figure 3).61 An increase in 
preload induced by volume expansion will increase stroke volume until the plateau phase.62 The Frank-Starling 
relationship also depends on ventricular function, and the curve is flattened when ventricular function is 
impaired.62 Mechanical ventilation induces cyclic changes in vena cava blood flow, pulmonary artery blood flow, 
and aortic blood flow.63 As a consequence, mechanically ventilated patients present with cyclic changes in left 
ventricular stroke volume.64 These respiratory variations are related to the patient´s fluid status, and in 
hypovolemic patients, the systolic pressure variation (SPV) is frequently over 10 mmHg.65 SPV is an accurate 
predictor of fluid responsiveness in adult patients undergoing noncardiac surgery.66 The dynamic indices SPV, 
PPV, and SVV predict fluid responsiveness in mechanically ventilated patients accurately.67  
 
SVV correlates well with SPV in cardiac surgery patients.68  In response to a 500 mL fluid challenge in coronary 
artery bypass grafting patients, SVV of more than 10% predicted a 15% increase in CO at a sensitivity of 82% 
and a specificity of 87%.69 Dynamic parameters of fluid responsiveness such as SPV, SVV, and PPV have 
several limitations. These parameters must be used in fully sedated, mechanically ventilated patients, with a tidal 
volume of at least 8 mL/kg of body weight, sinus rhythm, and an intra-abdominal pressure within normal 
ranges.62 Furthermore, accuracy of APCO may be limited during rapid changes in vascular resistance, for 





Figure 3. The Frank-Starling curve. Increasing preload induces a decrease in PPV (from 2 to 3). PPV is minimal 
when the heart is operating on the plateau of the curve (3 and 4). Decreasing preload induces an increase in PPV 
(from 2 to 1), also increasing contractility (from 4 to 2). © Biomed Central. Michard and colleagues. Crit Care 
2007;11:131, doi:10.1186/cc5905. Permission to reproduce granted under BioMed Central´s general terms. 
  
 
INTRAVENOUS FLUIDS IN NEUROSURGERY 
 
CRYSTALLOID SOLUTIONS  
 
Crystalloids contain no high-molecular-weight compounds and thus have an oncotic pressure of zero. Isotonic 
crystalloids distribute evenly across the whole extracellular compartment, only 20% remaining in the vascular 
compartment.32 According to a study in surgical patients, the intravascular volume effect of lactated Ringer´s 
(LR) solution is 17 ±10%.71  
 
Crystalloids may be hypo-osmolar, iso-osmolar, or hyperosmolar. In healthy volunteers receiving 50 mL/kg LR 
solution (273 mOsm/L) and 0.9% saline (308 mOsm/L), LR transiently reduced serum osmolality, whereas 
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normal saline failed to change serum osmolality but caused metabolic acidosis.72 Saline-based fluids are 
associated with risk for hyperchloraemic metabolic asidosis.73  Ringer´s solutions are buffered with either lactate 
or acetate. The composition of ions in RAC is very close to that of the extracellular fluid, but RAC (270 mOsm/l) 
is slightly hypo-osmolaric in relation to plasma (295 mOsm/l); therefore additional sodium may be needed. 
Serum osmolality affects brain water content, so that low serum osmolality may contribute to cerebral oedema.74 
Hypo-osmolar solutions should be avoided in neurosurgical patients.75 
  
Moderate haemodilution with crystalloids in patients undergoing peripheral vascular surgery under regional 
anaesthesia induces an enhanced coagulation state as measured by thromboelastograph (TEG) analysis and in 
routine coagulation studies.76 The mechanism is related to rapid haemodilution; possibly to a reduction in 
anticoagulant factors such as antithrombin III.76  This hypercoagulability continues into the postoperative period 
77 and is also suggested to elevate the incidence of deep vein thrombosis.78 
 
 Extracellular losses, such as urinary output and perspiration, should be replaced with isotonic crystalloids.32  
Optimal perioperative fluid therapy is suggested to include a combination of fixed crystalloid to replace 
extravascular losses and avoidance of fluid excess, together with individualized goal-directed colloid 
administration to maintain maximal stroke volume.15 The clinical studies of GDT all include administration of 
colloids, 79 and GDT-administered crystalloid has only been studied in animal models.80, 81    
 
COLLOID SOLUTIONS  
 
Albumin, dextran, gelatin, and HES solutions are efficient plasma expanders widely used in the replacement of 
fluid volume for surgical patients. The duration of the volume effect of colloids varies according to their 
molecular weight. Gelatins and albumin are more likely to leak into the interstitial space, whereas HES solutions 
are retained in the blood circulation longer.82 The osmolarity of colloids is dependent upon the carrier solution; 
for example, 6% tetrastarch (HES 130/0.4) is dissolved in normal saline (308 mOsm/l). According to one 
systematic review no evidence exists that any one particular colloid is safer or more effective.83 A previous 
systematic review has also suggested that colloids are no more effective than crystalloids in reducing mortality 




Safety is a concern with regard to coagulopathy, renal failure, and mortality associated with HES solutions, and 
although HES solutions with a lower molecular weight and degree of substitution such as HES 130/0.4 are 
considered safer, evidence may be insufficient to support this.85  The impact of the raw material of HES solutions 
(potato-derived versus waxy maize-derived) has been discovered in recent years, and waxy maize-derived 6% 
HES 130/0.4 may have advantages.86 In healthy volunteers, the pharmacokinetic properties of the waxy maize-
derived and potato-derived solutions differed, 87 and a recent experimental study also suggests differing 
biological effects of these two starch types.88  
 
The effects of HES solutions on blood coagulation both in vitro and in vivo that observed with TEG increase in a 
dose-dependent manner, including a decrease in the rapidity of clot formation and clot strength.89 Compared to 
other HES solutions, HES 130/0.4 has the smallest effect.89 No disturbance of haemostasis occurred in 
neurosurgical patients receiving 1000 mL of 6% HES (Plasmasteril®), although HES prevented the 
postoperative increase in factor VIII activity that otherwise would contribute to postoperative 
hypercoagulability.90 
  
Recently two large studies (6S trial and CHEST study) comparing HES 130/0.4 to a crystalloid for fluid 
resuscitation in patients with severe sepsis have reported an increased risk for acute kidney injury or need for 
renal replacement therapy with HES 130/0.4.91, 92 Results regarding patient survival differed between these two 
studies, with no difference in 90-day mortality between groups in the CHEST study.92 In the CRYSTAL study, 
which investigated mortality in ICU patients treated with any available crystalloid compared to any available 
colloid, colloid resuscitation reduced 90-day mortality in patients suffering from sepsis or nonseptic shock, but 
not in trauma patients. (Djillali Annane, FRACTA meeting 2013). Conflicting results concerning use of modern 
starch solutions in septic patients may at least partly be due to differences in transfusion protocols, with early or 
late fluid resuscitation, and to nonprotocolized or protocolized infusion of fluids. The CRYSTMAS study with 
early goal-directed therapy in hypovolemic patients with severe sepsis showed no differences in adverse events 
between patients treated with HES 130/0.4 or with isotonic saline.93 The consensus statement of the ESICM task 
force on colloid volume therapy in critically ill patients suggests avoidance of 6% HES 130/0.4 or gelatin in 
patients with severe sepsis or risk for acute kidney injury, and recommend no use of colloids in patients with 
head injury.94 This recommendation of no colloids for head injury is under debate with the suggestion that 
albumin and gelatin may increase risk for brain oedema through low osmolarity, irrespective of the colloid 
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preparation itself.95  The concern is that in patients with an impaired blood-brain barrier, HES solutions may 
penetrate into the brain interstitium, despite the absence of HES in cerebrospinal fluid.96 On the other hand, a 
reduction in colloid oncotic pressure can aggravate traumatic brain oedema.97   
  
In surgical patients without an elevated risk for acute kidney injury, colloid use is still an open question. In one 
recent review were no indications that tetrastarches (HES solutions with molar substitution ratio 0.4 or 0.42) 
used intraoperatively or in the immediate postoperative period induce adverse renal effects, increased blood loss, 
or increased mortality.98 Most studies in the perioperative setting have a small sample size and a short follow-up 
time, however, and are unsuitable for conclusions as to HES-solution safety.  Approaching the question of 
colloid safety physiologically, focusing on mechanisms behind the acute kidney injury, an experimental study 
found that normovolemic haemodilution with crystalloids but not starches (HES 6% 130/0.4) reduced 
microcirculation in the kidney.99   
  
A common belief that intravascular volume replacement with crystalloid solutions requires three times as much 
fluid or even more than for colloids.100  According to recent studies in critically ill patients, the crystalloid-to-
colloid-volume ratio is in fact more in the range of 1 to 2.101 In the perioperative setting, crystalloid-to-colloid 
volume ratios have not been systematically assessed.  With progressive normovolaemic haemodilution, as in the 
case of acute bleeding, the requirement of crystalloid to blood loss is, however, fivefold, and colloids may 
prevent interstitial fluid accumulation.71 There is an indication for colloids in the replacement of plasma deficits 




Hyperosmotic fluids are useful in fluid resuscitation not only for patients with haemorrhagic hypovolemia but 
also for patients with intracranial hypertension. Hyperosmolar therapy with either mannitol or hypertonic saline 
reduces ICP by reducing brain volume.19 Mannitol induces osmotic diuresis, whereas hypertonic saline increases 
serum osmolarity directly.19 Mannitol is administered to improve surgical conditions during craniotomy, but  
rebound increase in intracranial pressure has been a concern; 102  after high doses of mannitol, one complication 
is acute kidney injury.103 Renal insufficiency is usually transient and completely reversible.104 With hypertonic 
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saline, possible concerns are the sodium load and hypernatremia.75 The patient´s haemodynamic status and renal 




LR and more recently developed balanced solutions are buffered and have electrolyte compositions close to that 
of plasma. Traditionally, HES is dissolved in isotonic saline, but solutions now developed contain HES dissolved 
in balanced electrolyte solutions.  Infusion of large volumes of saline results in hyperchloraemic metabolic 
acidosis.105 The clinical relevance of the hyperchloraemic metabolic acidosis is debatable, but it has been 
associated with increased need for blood products106 as well as renal cortical tissue perfusion reduction.107 
According to one retrospective cohort trial in noncardiac surgical patients, the incidence of acute postoperative 
hyperchloremia was 22%.108 The hyperchloremia was associated with increased risk of 30-day mortality.108  
Administration of completely balanced fluids (crystalloid and colloid) to surgical patients also has resulted in 
better gastric mucosal perfusion than with saline-based solutions.109 In a retrospective cohort study regarding 
replacement of fluid losses on the day of surgery, compared to normal saline balanced crystalloid was associated 
with less postoperative morbidity.110  
 
Important for optimal coagulation capacity is acid-base- and electrolyte homeostasis.111 Balanced solutions are 
hypothesized to interfere less with coagulation, but according to one study in volunteers receiving 20 mL/kg 
balanced (Vitafusal®) or saline-based (Venofundin®) tetrastarch 6% 130/0.42, the effect of the carrier solution 
on platelet aggregation and clot formation assessed by blood aggregometry and rotational thromboelastometry 
was minimal.112 In surgical patients, however, 6% hetastarch in a balanced-saline vehicle (Hextend®), as 
determined by thromboelastography, was associated with minimal effect on haemostasis, compared to that of 6% 
hetastarch in normal saline (Hespan®) that induced hypocoagulation. 77 
 
PERIOPERATIVE COAGULATION MANAGEMENT 
 
For patients undergoing any surgery, perioperative monitoring of coagulation aims for increased safety.113 In 
neurosurgical patients, abnormal haemostasis leading to bleeding complications can cause severe impairment, or 
even death.114 In guiding coagulation management perioperatively, routine coagulation tests (prothrombin time, 
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International Normalized Ratio (INR), activated partial thromboplastin time, fibrinogen) have limitations, such 
as delayed test results, insufficient differential diagnosis of acquired intra-operative coagulopathy, and 
insensitivity to the function of fibrinogen, hyperfibrinolysis, and platelet dysfunction.113  Perioperative visco-
elastic point-of-care testing enables early detection of the underlying coagulopathy.114 The advantage of these 
techniques is that they measure the entire clotting process bedside, with minimal delay.115 
 
Since thromboelastography was first described in 1948 by Hartert, the visco-elastic whole blood testing of today 
has developed thromboelastography (TEG®), thromboelastometry (ROTEM®), and the Sonoclot® analyzer.116 
These all measure shear-elastic features during clot formation in recalcified citrated or noncitrated blood and 
provide graphical representations as well as numerical data for such parameters as time to clot, rate of formation 
of the clot, strength of the clot, and stability of the clot, along with assessment of fibrinolysis.116 ROTEM® 
improved the original TEG® procedure and implemented test modifications to facilitate differential diagnosis, 
such as fibrinogen deficiency, thrombocytopenia, prolonged clot generation due to various coagulation-factor 
deficiencies, or to heparin, and impaired clot stability due to hyperfibrinolysis and factor XIII deficiency.113   
 
A normal ROTEM® tracing is in Figure 4. EXTEM uses recombinant tissue factor to activate coagulation and 
assess coagulation through the extrinsic pathway.113  In the FIBTEM test, cytochalsin D, a platelet inhibitor, 
allows assessment of the contribution of fibrinogen to clot strength.113 Comparing FIBTEM and EXTEM results 
permits differentiation of a low platelet count from dys- or hypofibrinogenaemia.113 In the APTEM test, 
aprotinin inhibits fibrinolysis, and the degree of fibrinolysis is assessed by comparison of EXTEM and APTEM 
results.113 INTEM uses ellagic acid contact activator to analyze general coagulation status through the intrinsic 
pathway.113 HEPTEM can serve to detect specific anticoagulant effects.113 
 
Criticism has araisen against viscoelastic point-of-care coagulation monitoring because these tests are hard to 
standardize.115 Concern arises about quality control, but according to a recent study, the reproducibility of 
ROTEM® was not influenced by its performance bedside or, alternatively, in the hospital laboratory.117 
Influences on the parameters determined by ROTEM® are age, gender, and oral contraception; adjustments for 




In neurosurgical patients, TEG® revealed increased coagulability during surgery, changes more pronounced in 
patients undergoing craniotomy than in patients undergoing spinal procedures.119 Thromboplastin, an activator of 
the extrinsic pathway of the coagulation cascade, is released during intracranial surgery and may contribute to 
the hypercoagulability.120  
 
According to one systematic review, use of TEG® or ROTEM® in patients with massive transfusion reduced 
bleeding and reduced the proportion of patients requiring transfusion of both platelets and fresh frozen plasma, 
although with no effect on patient survival.121 In surgical patients, point-of-care-guided coagulation management 




Figure 4. Normal thromboelastometry (ROTEM®) tracing and parameters. From “A Practical Guide to 













AIMS OF THE STUDY 
 
 
The main objective of the study was to examine the circulatory and coagulation variables during goal-directed 
fluid therapy with a crystalloid or a colloid in patients undergoing neurosurgery in the prone or sitting position. 
 
 
The specific aims were to determine:  
 
1. the haemodynamic profile and the incidence of venous air embolism (VAE) in patients undergoing 
surgery in the sitting position (I, II). 
2. the volumes of HES 130/0.4 and Ringer´s acetate required for stable haemodynamics during 
neurosurgery in the sitting position by use of stroke volume-directed administration of fluids (II). 
3. the volumes of HES 130/0.4 and Ringer´s acetate required for stable haemodynamics during 
neurosurgery in the prone position by use of stroke volume-directed administration of fluids (III). 
4. the effect of a totally balanced fluid concept on whole blood coagulation in vitro (IV). 






























PATIENTS AND METHODS 
 
This study was carried out at Töölö Hospital, Helsinki University Central Hospital, Helsinki, Finland, during 
2008 to 2012.  Altogether 60 neurosurgical patients (Studies II, III) and 22 volunteers (Studies IV, V) were 
recruited for the study (Table 1). In addition, the anaesthesiology reports of 72 neurosurgical patients were 
reviewed retrospectively (Study I). All the studies were approved by the ethics committee of the hospital district, 
and Studies II and III were also approved by the National Agency of Medicines in Finland. All patients and 
volunteers gave their written informed consent.  Characteristics of the study fluids are in Table 2. 
 
  
Table 1. Study characteristics. 
 
Study Subjects n Design Intervention Primary end-
point 
I Neurosurgical 
patients: sitting  
72 Retrospective None Haemodynamic 
stability and 
incidence of VAE  
II Neurosurgical 






HES 130/0.4 or 
RAC 
Volumes of HES 
and RAC  
III Neurosurgical 






HES 130/0.4 or 
RAC  
Volumes of HES 
and RAC  
IV Healthy 
volunteers 




































HES= hydroxyethyl starch, MCF= maximum clot firmness, RAC= Ringer´s acetate, ROTEM= rotational 


















Study II,III,IV,V IV II, III,IV,V IV IV V 
Average MW, 
kDa 
- - 130 130 30 182 
pH 6.0 4.6-5.4 4.0-5.5 5.7-6.5 7.1-7.7 4.5-7.0 
Sodium, 
mmolL-1 
131 140 154 137 154 - 
Chloride, 
mmolL-1 
112 127 154 110 120 - 
Potassium, 
mmolL-1 
4 4 - 4 - - 
Calcium, 
mmolL-1 
2 2.5 - - - - 
Magnesium, 
mmolL-1 
1 1 - 1.5 - - 
Acetate,  
mmolL-1 
30 24 - 34 - - 
Malate, 
mmolL-1 
- 5 - - - - 
Osmolarity, 
mOsmL-1 
270 309 308 286.5 274 825 
 
GEL=gelatin, HES= hydroxyethyl starch, MW=molecular weight, RAC= Ringer´s acetate  
 
RETROSPECTIVE STUDY (I) 
 
In Study I, anaesthesiology reports of 72 patients, aged 1-78, treated for pineal region tumours in the sitting 
position in 1997-2007 were reviewed for haemodynamic stability and incidence of VAE. VAE was defined as an 
embolic heart sound by precordial Doppler ultrasound, a 0.7 kPa or greater decrease in end-tidal concentration of 
carbon dioxide (ETCO2), or identification of an air leak at the surgical site. 
 
PROSPECTIVE CLINICAL STUDIES (II, III) 
 
Patients 
Thirty adult neurosurgical patients undergoing surgery in the sitting position (Study II) and thirty adult 
neurosurgical patients undergoing surgery in the prone position (Study III) were randomized to receive either 
HES 130/0.4 or RAC according to SV-directed administration of fluids. Exclusions were age <18, body mass 
index (BMI) >36 (kg·m-2) (Study III) or >40 (kg·m-2) (Study II), congestive heart failure, other than sinus 
rhythm, renal failure (P-creatinine>120 micromol·L-1), hepatic failure, anaemia (haemoglobin concentration, Hb 
 
Table 2. Characteristics of the study solutions  
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<100 g·L-1), thrombocytopenia (platelet count, Plt <100 ·109 L-1), and anticipated need for mannitol during the 
surgery.  Also observed were general contraindications for the sitting position such as known open foramen 
ovale, ventriculoatrial shunt, uncontrolled hypertension, cerebral ischaemia when upright and awake, right atrial 
pressure greater then left atrial pressure, and age >80 years (Study II). 
 
Anaesthesia 
Patients fasted for at least 6 hours preoperatively.  Preoperative cardiac medication was administered on the 
morning of surgery, except for angiotensin-converting enzyme inhibitors and angiotensin II antagonists. Oral 
diazepam 5-20 mg served for premedication. All patients received a basal infusion of RAC started at a rate of 3 
mL·kg-1h-1 before induction of anaesthesia. Preoperative antibiotics (cefuroxime or vancomycin) were 
administered to all. Anaesthesia was induced in the supine position with fentanyl 2-7 microg·kg-1 and either 
thiopenthal 2-7 mg·kg-1 or propofol 2-3 mg·kg-1. All patients were given glycopyrrolate 0.2 mg and rocuronium 
(0.5-0.9 mg·kg-1) for muscle relaxation. Anaesthesia was maintained with sevoflurane (1 minimal alveolar 
concentration, MAC) in a mixture of nitrous oxygen and air (Study III), or a continuous infusion of propofol (4-
12 mg·kg-1·h1) and remifentanil (0.05-0.45 microg·kg-1·h1) (Studies II and III). The patients were tracheally 
intubated and mechanically ventilated with volume-controlled ventilation for a tidal volume of 8 to10 mL·kg-1 
body weight at a rate of 10-15 min-1 for normoventilation (target arterial carbon dioxide tension, PaCO2 4.5 to 




Our routine monitoring consisted of  non-invasive arterial pressure, electrocardiography (ECG) (lead II), arterial 
saturation of oxygen (SpO2), and after intubation and the start of mechanical ventilation, nasopharyngeal 
temperature, side-stream spirometry (Side stream®, Datex-Ohmeda Inc, GE Healthcare, Madison, WI, USA), and 
ETCO2. Invasive monitoring of arterial pressures and blood samples was obtained through a 20-G arterial 
catheter (Becton Dickinson, Temse, Belgium) inserted into the radial artery after the induction of anaesthesia.  A 
pressure transducer (FloTrac®, Edwards Lifesciences, Irvine, CA, USA) was connected to the radial arterial line 
and to the Vigileo® System (Edwards Lifesciences) with software v 3.02. This device enables continuous 
monitoring of CO by pulse contour analysis without external calibration. The system provides CO, CI, SV, SVI, 
and SVV. Invasive arterial blood pressure was measured at the level of the heart (Study III) or at the level of 
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foramen Monro (Study II) through a second blood pressure transducer set connected to the radial arterial line. 
Target mean arterial pressure (MAP) was 60 mmHg or higher, and if MAP was below 60 mmHg, boluses of 
phenylephrine (0.05-0.1 mg) or ephedrine (5-10 mg) were provided. If MAP remained below 60 mmHg for 
longer than 5 min, a phenylephrine-infusion was started. In the sitting position (Study II) the probe of precordial 
Doppler (Versatone D8 Perioperative Doppler; MedSonics Inc, Mountain View, CA, USA) was attached to the 
right of the sternum over the fifth intercostal space.  
 
Fluid boluses 
In the supine position after induction of anaesthesia, an initial 200 mL bolus of the study fluid was infused over 2 
to 4 minutes, and haemodynamic measurements were performed before and 3 min after the volume expansion. 
Thereafter, 100-mL boluses were infused over 2 to 4 minutes. Haemodynamic measurements were performed at 
3 min after the completion of each bolus, and a new bolus was given immediately after the measurements, until 
the SV increase was no more than 10%. In the sitting (Study II) or prone (Study III) position, measurements 
during surgery were performed at 5-min intervals. If SV decreased more than 10% from the value obtained in the 
supine position, further boluses of 100 mL of the study fluid were infused. If the SV did not increase with three 
consecutive boluses of study fluid during surgery, volume expansion was stopped, and the patient was 
considered a non-responder. Finally, haemodynamic measurements were performed at the end of surgery, and in 
the supine position. Postoperatively, the basal infusion of RAC was given at a rate of 1 mL·kg-1h-1 to all patients 
until the following morning.  
 
Type of surgery 
In Study II, all patients underwent elective craniotomy. Study III included several types of elective neurosurgery: 
spinal surgery at the cervical, thoracic or lumbar site, Chiari surgery (decompression of posterior fossa) and 
craniotomy.   
 
IN VITRO STUDIES (IV, V) 
 
In Study IV, venous blood collected from six healthy male and six healthy female volunteers aged 19 to 28 was 
diluted to 20% and 40% end-concentrations with a combination of equal amounts of colloid (balanced or 
unbalanced HES 130/0.4 or gelatin) and crystalloid (balanced or unbalanced RAC) in vitro. In Study V, venous 
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blood samples from seven healthy male and three healthy female volunteers aged 22 to 44 were diluted to 10% 
and 20% end-concentrations with mannitol (15% Mannitol) alone, mannitol and RAC, and mannitol and HES 
130/0.4 in vitro. None of the volunteers was on regular medication, and any drug affecting haemostasis was 
forbidden for at least 5 days before blood sampling. Hb, haematocrit value (Hct), and Plt were determined in 
whole blood and in the diluted samples. All blood samples were analyzed with modified thromboelastometry 




In the clinical studies (II and III), arterial blood samples were collected after the induction of anaesthesia (Pre), 
after the total amount of boluses of the study infusion given in the supine position before positioning (Post), and 
at the end of surgery (End) via a non-heparinized radial artery catheter. Blood samples were collected into 
polypropylene tubes containing 3.2% buffered citrate. In the in vitro studies (IV and V), each venous blood 
sample was obtained from an antecubital vein directly into a vacuum polypropylene tube containing 3.2% 
buffered citrate. Immediately after sampling, part of the whole blood was diluted with the test solutions in 
random order. An undiluted citrated blood sample served as a control. 
 
For Studies II to V, modified thromboelastometry coagulation analysis (ROTEM®; Pentapharm GmbH, Munich, 
Germany) was performed within 2 hours after blood withdrawal. Studies IV and V used extrinsic ROTEM 
(tissue coagulation activator, EXTEM®) and fibrinogen ROTEM (FIBTEM®), and Studies II and III had an 
additional two tests performed: intrinsic ROTEM (contact coagulation activator, INTEM®) and aprotinin 
ROTEM (APTEM®)). Coagulation was allowed to proceed for at least 30 minutes. Automatically measured 
ROTEM® variables were clotting time (CT,s), clot formation time (CFT,s), α-angle (degree), and maximum clot 
firmness (MCF, mm).  
 
In Studies II and III blood samples were analysed for Hb, Hct, and Plt with the Sysmex K-4500® (Sysmex 
Corporation, Kobe, Hyogo, Japan). In Study IV, blood samples were analysed for Hb, Hct, and Plt with the 
Sysmex KX-21N haematology analyser® (Sysmex America, Mundelein, IL, USA). Study V blood samples were 
analysed for Hb, Hct, and Plt with the Cell-Dyn 610 Haematology Analyser® (Sequoia-Turner Corporation, 
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Mountain View, CA, USA). Arterial blood gases were analysed in Studies II and III with the Radiometer 




All data were analysed by the following statistic software: Stat View PowerePC Version 5.0 (SAS 
Institute Inc, Cary, NC, USA), SPSS (version 17.0 or 18.0), SigmaStat (version 2.03) for 
Windows software (SPSS Inc., Chicago, IL), or R-program (version 3.0.0) nlme package. 
 
Parametric variables are reported as the mean with standard deviation (SD) or standard error of the mean (SEM) 
or 95% confidence interval. Skewed data are shown as medians with range. Kolmogorov-Smirnov was used for 
testing normality. Differences between groups were evaluated by ANOVA or Chi-square (Study I), the Mann-
Whitney U-Test (Studies II, III, V), linear mixed model (Study III) or ANOVA for repeated measures with the 
Tukey-Kramer post hoc test (Study IV). Differences within groups were tested by the Wilcoxon Signed Rank 
test (Studies II, III, V) with the post hoc Bonferroni correction, ANOVA on ranks and linear mixed model 
(Study III), or student´s t-test (Study IV). P<0.05 was considered statistically significant.  
 
To estimate required sample sizes, power analysis was performed during study planning. Studies II and III were 
designed to discover a threefold difference in required volume of study fluid between groups, limiting the risk 
for Type I error to less than 0.05, while keeping the risk for a Type II error at less than 0.2. On the basis of our 
previous study, the number of subjects per group is also sufficient to detect a difference of 15% in MCF of the 
thromboelastometry.123 In Study IV, 12 volunteers were considered necessary to detect a 15% difference in MCF 
between the groups, and in Study V, the number of volunteers required to discover a difference greater than 1 SD 











All patients and volunteers initially included completed the study, but for one patient in each group in Study II, 
the fluid management protocol was violated, and the data of these two patients were not analysed.  In both 
Studies II and III, one of the patients in the RAC group required a mannitol bolus because of inadequate brain 
relaxation. The data of these two patients were analysed until the administration of mannitol, applying the 
intention-to-treat principle. All haemodilutions in Studies IV and V were successful. Of all the 




After patient placement in the sitting position, median systolic arterial pressure (SAP) decreased 8 (-95 to + 50) 
mmHg (Study I). Positioning was accompanied by a more than 20% decrease in SAP in 38% (Study I) and 25% 
(Study II) of the patients, whereas SAP was stable during surgery (See Study I, Fig 3, p.509). Of all patients, 
69% (Study I) and 82% (Study II) received vasoactive drugs.  In Study II, heart rate (HR) and MAP did not 
differ between groups during positioning or in the sitting position. CI and SVI increased during surgery in the 
HES group (P<0.05) but not in the RAC group (NS) (See Study II, Figure 2, p.734). No significant differences 
occurred between the groups regarding the total amount of vasoactive drugs used, neither for phenylephrine 
(P=0.729) nor for ephedrine (P=0.317).  Doses of the continuous infusion of propofol (P>0.05), as well as the 
total dose of propofol (P=0.581), were comparable between groups. No difference in the total dose of fentanyl 
(P=0.307), remifentanil boluses (P=0.926), remifentanil infusion (P=0.748), or amount of local anaesthetics 
(P=0.405) emerged between groups.   
 
In the prone position (Study III), neither HR or SVI differed between the groups during the entire study period; 
CI and MAP increased in the HES group (P<0.05), however, but not in the RAC group (NS) (See Study III, 
Figure 2, p.16). No significant differences emerged between groups as to total amount of vasoactives, neither for 
phenylephrine (P=0.755) nor for ephedrine (P=0.239). End-tidal concentrations of inhaled sevoflurane were 
comparable between groups (P>0.05), and doses of the continuous infusion of propofol (P=0.768), as well as the 
total dose of propofol (P=0.725) were comparable between groups, with no difference between groups in total 
dose of fentanyl (P=0.653), remifentanil (P=0.195), or the amount of local anaesthetics (P=0.348).  
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INCIDENCE OF VAE 
 
VAE was observable in 19% (Study I) and 50% (Study II) of the patients operated on in the sitting position. In 
Study I, five patients had a greater than 0.7 kPa decrease in ETCO2 as the only indication of VAE, resulting in a 
26% incidence of VAE in this retrospective study. Study II showed no difference in incidence of VAE between 
the RAC and HES groups (P=0.458). VAE was usually detected at the beginning of surgery. None of the patients 
needed to be repositioned during surgery. According to Study I findings, all VAE patients had normal peripheral 
oxygen saturation during the whole period of surgery, and the changes in SAP were comparable to those of the 
no-VAE group.  One patient with VAE developed bilateral infiltrates in the postoperative chest x-ray, but these 
changes disappeared on the first postoperative day. Neither duration of ventilator treatment nor hospital stay 
differed between the VAE- and no-VAE groups in Study I. All clinical or radiological signs of complications 
referable to systemic arterial air embolism were absent.  
 
VOLUMES OF FLUIDS 
 
Compared to HES, the mean cumulative dose of RAC needed to optimize fluid filling at 30 min after the sitting 
positioning was significantly higher (P<0.05), and the intraoperative fluid balance was more positive in the RAC 
than in the HES group (P=0.044, 95% CI -978 to -14) (Table 3). Comparable haemodynamics were achieved 
with the mean (SD) cumulative doses of HES or RAC 271 (47 mL) or 264 (50 mL) (P=0.699) before the sitting 
position, 343 (94) or 450 (156) (P=0.036) at 30 min after the positioning, and 464 (284) or 707 (425) 
respectively (P=0.087) at the end of surgery.  
 
Compared to HES, the mean cumulative dose of RAC needed to optimize fluid filling at 30 min after the prone 
positioning was significantly higher (P<0.05). Comparable haemodynamics were achieved with the mean (SD) 
cumulative doses of HES or RAC 240 (51 mL) or 267 (62 mL) (p=0.207) before the prone position, 340 (124) or 
453 (160) (p=0.039) 30 min after the positioning, and 440 (229) or 653 (368) respectively (p=0.067) at the end 












HES (II) RAC(II) HES (III) RAC (III) 
Pre  
Dose (mL) 
271 ± 47 
 
264 ± 50 
 
240 ± 51  
 
267 ±62  
30 min  
Dose (mL) 
343 ± 94 * 
 
450 ± 156 * 
 
340 ± 124 * 
 
453 ± 160 * 
End  
Dose (mL) 
464 ± 284 
 
707 ± 425 
 
440 ± 229 
 
653 ± 368 
Total basal RAC  
Dose (mL) 
750 ± 202 
 
767 ± 240 
 
813 ± 235 
 
868 ± 354 
Intraoperative blood 
loss (mL) 
106 ± 106 
 
136 ± 145 
 
216 ± 160 
 
201 ± 278 
Intraoperative urine 
output (mL)  
754 ± 671 
 
488 ± 276 
 
352 ± 262 
 
407 ± 480 
Intraoperative fluid 
balance (mL) 
612 ± 650 * 
 
1108 ± 520  * 
 




Cumulative amounts of study fluids administered before the position (Pre), 30 min thereafter (30 min), and at the 
end of surgery (End). Values are mean ± SD. 
*P<0.05 between groups 





In Study II, thromboelastometry data were comparable between the groups (Table 4), and no difference emerged 
in blood loss between groups (P=0.536). Study III revealed a difference in FibTEM α-angle between the groups, 
although the clinical relevance of this finding is unclear. The formation and maximum strength of the fibrin clot 
were lower in the HES group, unlike in the RAC group (Table 4). In FibTEM analyses, α-angle (P=0.037) and 
MCF (P=0.012) decreased at the end of surgery in comparison with the baseline in the HES group, but in the 
RAC group these characteristics remained unchanged. In Study III, only one patient in the HES group needed 
transfusion of packed red blood cells during surgery, and intraoperative blood loss was comparable between 
groups (P=0.861). 
 













Table 4 ROTEM® results before (Pre), and after boluses of study fluid (Post), and at the end of surgery (End) in 
Studies II and III. 
   
 HES (II) HES (III) RAC (II) RAC (III) 















































































































61.0 (32-77) # * 
 
















































Values presented as median (range).  
 # P<0.05 in comparison with Pre within the group (Wilcoxon Signed Rank Test). 
* P<0.05 HES in comparison with RAC (ANOVA) 
HES= hydroxyethylstarch 130/0.4, MCF= maximum clot firmness, RAC= Ringer´s acetate 
  
 
The totally balanced fluid concept with a combination of balanced colloid and balanced crystalloid solutions has 
negative effects on whole blood coagulation comparable to those of combination of the respective unbalanced 
solutions in vitro (See Study IV, Figures 1-4, p.424-5). In EXTEM analyses, CT and CFT were prolonged in all 
20- and 40 vol% dilutions with both balanced and unbalanced HES solutions compared to the control (P<0.05). 
In contrast, CT remained unchanged in the gelatin-diluted samples after 20 vol% haemodilution. MCF decreased 
in all the samples in comparison to the control after 20- and 40 vol% haemodilution in both EXTEM and 




As measured by thromboelastometry, mannitol impaired whole blood coagulation. This impairment associated 
with mannitol was evident because of the delayed initiation of coagulation and fibrin formation (prolonged CFT), 
and decreased MCF in vitro. This effect was more pronounced with a greater degree of dilution and more 
pronounced for mannitol in combination with HES (See Study V, Tables 3 and 4, p.18). Because samples with 
similar mannitol concentration were compared, MCF decreased more in 20 vol% mannitol with HES than in 10 
vol% mannitol in both EXTEM and FIBTEM analyses (P<0.05).  No significant difference appeared in MCF 



























SITTING POSITION AND HAEMODYNAMICS 
 
The sitting position was associated with risk for hypotension in Studies I and II (38% and 25% of patients), 
especially during the positioning period. Depending on definition, the incidence of hypotension in association 
with the sitting position has ranged from 5 to 32%.4 Our results are in accordance with these findings. GDT-
administered fluid therapy with crystalloid or colloid before positioning in Study II did not prevent the 
hypotension induced by positioning (Figure 5), but provided stable haemodynamic values during the sitting 
position (See Study II, Figure 2, p.734). Despite fluid loading with 7 mL/kg crystalloid (Eufusol®) or 7 mL/kg 
colloid (Gelafundin®) before the sitting position, Buhre and coworkers found a 24% decrease in CI. In our study, 
CI remained stable with 9 mL/kg crystalloid (Ringer´s acetate); with 6 mL/kg colloid (Voluven®) CI even 
increased.  
Figure 5. 










supine sitting supine 
Mean arterial pressure (MAP) at the level of foramen Monro (mean with standard 
error) in supine (before and after administration of 200 and 300 mL of the study 
solution, and after dressing of antigravity suit), sitting (0-150min at 5 min intervals 
and at the end of surgery), supine, and postoperatively. No significant difference 
appeared in MAP between groups during the entire study period. 
HES=hydroxyethylstarch 130/0.4, RAC=Ringer´s acetate 
Figure 1A. Mea  arterial pressure at the level of foramen Monro  (mea  with standard rror) in 
supine (before and after administration of 200 ml and 300 ml of the study solution; and after 
dressing of G-suit),  sitting (0-150 min at five min interv ls nd at the end of surgery), and in 













































Mean arterial pressure (MAP) at the level of foramen Monro (mean with standard 
error) in supine (before and after administration of 200 and 300 mL of the 
study solution, and after dressing of antigravity suit), sitting (0-150min at 5 min 
intervals and at the end of surgery), supine, and postoperatively. No significant 
difference ap-peared in MAP between groups during the entire study period. 




SITTING POSITION AND VAE 
 
The sitting position was associated with risk for VAE in Studies I and II (26 and 50%) especially during the 
beginning of surgery. These findings are in line with previous ones, in which the incidence of VAE diagnosed by 
precordial Doppler has been 25 to 50% of patients undergoing craniotomy in the sitting position.4 In Study II, 
VAE was diagnosed by precordial Doppler or by a 0.3-kPa or greater decrease in ETCO2. The magnitude of 
ETCO2 change indicating VAE ranges from 0.3 to 0.7 in the literature,124, 125 but for a prospective study the 
chosen value was considered appropriate. The incidence of VAE reported in Study I may have been 
underestimated due to the retrospective study design and the higher cut-off value for ETCO2 (>0.7kPa).   
 
GDT WITH CRYSTALLOID OR COLLOID AND FLUID BALANCE 
 
A crystalloid vs. colloid volume ratio of 1.0 before positioning and 1.5 at the end of surgery is lower than 
expected (Studies II, III). It is commonly believed that 2 to 3 times more crystalloid than colloid fluid is 
necessary to restore and maintain filling pressures in the treatment of hypovolemia.100 Recent studies have shown, 
however, that the volume ratio between crystalloid and colloid in the critically ill is in fact more in the range of 1 
to 2.101 Our results are in accordance with these findings. 
 
In Study II, the intraoperative fluid balance was more positive in the RAC than in the HES group, whereas in 
Study III, the intraoperative fluid balance was comparable between groups. In Study II, two patients (both in the 
RAC group) were classified as non-responders, and volume expansion was halted, whereas four patients (3 in the 
RAC group and 1 in the HES group) in Study III were classified as non-responders. A patient was considered a 
non-responder if the SV did not increase with three consecutive boluses of study fluid during surgery; in such 
cases, the volume expansion was halted. Without these limits for non-responders, the difference in fluid balance 
between the groups might have been more distinct. 
 
With GDT-administered crystalloid or colloid for patients undergoing neurosurgery in the sitting and prone 
position, the amount of RAC was 25 to 34% higher than the amount of HES to achieve a stable haemodynamic 
profile. However, most patients undergoing neurosurgery in the sitting and prone positions can be managed with 
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an acceptable volume of RAC instead of HES; the latter may cause a blood coagulation disturbance even at 
relatively low doses. Recently, administration of HES solutions in surgical patients has been questioned due to 
the possibly increased risk for renal insufficiency. No evidence exists as to the mechanism for renal insufficiency 
developing after colloid resuscitation, and the pathogenesis of acute renal failure in septic patients with low renal 
perfusion pressure in combination with capillary leakage differs.   
         
  
GDT WITH CRYSTALLOID OR COLLOID AND POSITIONING  
  
Studies II and III demonstrated that GDT-administered crystalloid is as effective as GDT-administered colloid in 
maintaining stable arterial blood pressure during neurosurgery in the sitting and the prone position, but the effect 
on CI was more favourable in the HES group in both of these positions. Colloid fluid loading in surgical patients 
has earlier been shown to lead to a greater cardiac response than with saline.100  The positive effect of GDT-
administered colloid on CI may justify administration of HES according to the goal-directed principle in 
hypovolemic patients requiring instant restoration of haemodynamics without excessive fluid load.  
 
In our studies, the volume of fluid (colloid/crystalloid) needed before positioning (Study II: 271/264 mL, Study 
III: 240/267 mL) was surprisingly low. Our studies also show that with GDT-administration of fluids, the prone 
and sitting positionings reduce CI neither in the HES nor in the RAC group.  In a study by Biais and coworkers, 
a bolus of 500 mL of 6% hetastarch before the prone positioning did not significantly prevent a decrease in CO 
in the prone position.126 Differences in study protocols, such as maintenance of anaesthesia, use of vasopressors, 
haemodynamic endpoints, fluid bolus volume, and time intervals for haemodynamic measurements, may explain 
the differences in CO response. In spinal surgery patients, the reduction in CO on turning patients prone was 
greater during maintenance of anaesthesia with propofol than with inhalation anaesthesia.127 Biais´s study had set 
measurements at a few predefined time intervals, but in Studies II and III, the haemodynamic measurements 
were performed throughout surgery at intervals of 5 minutes. Differences in positioning system with varying 
pressure on the inferior vena cava also affect the degree of haemodynamic changes in the prone position.128     
  
Haemodynamic response to fluid administration is largely dependent on the combined effect of the degree of 
hypovolemia, dosing regimen, and type of fluid. Patients in this study had a short fasting period preoperatively, 
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and their intra-operative blood loss was minimal. According to a study by Bundgaard-Nielsen and coworkers on 
GDT guided by oesophageal Doppler, 70% of patients had a functional intravascular volume deficit before 
surgery, and the median amount of colloid required to establish a maximal SV was 200 mL (range 200-600 
mL).129, 129 The volume of fluid required (200-300 mL of HES or 200-400 mL RAC) in our studies (II and III) is 
in accordance with these findings, but for the Bundgaard-Nielsen group, 15% of the patients had a clinically 
relevant volume deficit of ≥ 400mL. The fasting rules were the same, but their study included abdominal surgery 
patients, and they applied positive pressure ventilation which affects intravascular volume. In our study, the 
initial bolus of fluid was 200 mL, but further boluses were 100 mL in volume, increasing the sensitivity for  
reaching the threshold of optimal fluid filling.  
   
GDT WITH CRYSTALLOID OR COLLOID AND EFFECTS ON COAGULATION 
  
For RAC we found no effect on coagulation measured with thromboelastometry, but the effect of HES on 
coagulation measured with thromboelastometry varied among the studies. In Study III, the formation and 
maximum strength of the fibrin clot were decreased after an average dose of 440 mL of HES 130/0.4, whereas in 
Study II, an average dose of 460 mL of HES 130/0.4 did not impair the coagulation profile in 
thromboelastometry. The clinical relevance of these findings remains unclear. Intraoperative blood loss in these 
patients was very low and did not differ between the groups in either study. In neurosurgical patients, however, 
even minimal bleeding can have serious consequences. The volumes of fluids distributed were small; therefore 
the effect on haemostasis was minimal, and we observed no crystalloid-induced hypercoagulability.  
 
Study II involved craniotomy patients alone, whereas patients in Study III were mainly undergoing spinal 
surgery. An earlier study in neurosurgical patients showed increased coagulability by TEG® during surgery; 
these changes were more pronounced in patients undergoing craniotomy than in those undergoing spinal 
procedures.119 Heesen and coworkers showed that thromboplastin is released during intracranial surgery, a 
release that may contribute to the hypercoagulability.120 Differences in the effect of HES on coagulation, 
measured with thromboelastometry, between Studies II and III may in part be due to differences in type of 
surgery. Posture should also be considered a significant factor affecting coagulation; the sitting position is 
associated with increased viscosity in the lower limbs which could contribute to activation of the coagulation 
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system.130 Furthermore; VAE has been associated with a decrease in platelet count, and in vitro studies have 
shown that air-blood contact leads both to complement and to platelet activation.131  
 
GDT WITH CRYSTALLOID OR COLLOID AND OSMOLARITY 
 
Because RAC (270 mOsm/l) is slightly hypo-osmolaric in relation to plasma (295 mOsm/l), additional sodium 
was added to the basal infusion of RAC for the craniotomy patients in Study II. HES 130/0.4 is dissolved in 
normal saline (308 mOsm/l) and should not lower serum osmolality. In Study II, one patient in the RAC group 
needed a mannitol bolus, and two patients in the HES group were administered a bolus of hypertonic saline for 
treatment of brain swelling. In Study II, the neurosurgeon reported one case of difficulty with closing the wound 
of a patient in the RAC group due to clinically observed brain oedema. Otherwise no obvious brain swelling 
occured. Serum osmolarity was not measured.  
  
BALANCED FLUIDS AND EFFECT ON COAGULATION  
 
In Study IV, a totally balanced fluid concept offered no advantages regarding whole blood coagulation in vitro, 
as measured by thromboelastometry. Later, an ex vivo study by Schaden and coworkers confirmed this 
thromboelastometry finding in healthy volunteers and also concluded that the carrier solution of HES had a 
minimal effect on platelet aggregation.112 Further clinical studies are required to verify this finding in patients. 
 
MANNITOL AND EFFECT ON COAGULATION 
  
Although mannitol is commonly administered to neurosurgical patients to reduce ICP and improve surgical 
conditions during craniotomy, the possible effects of mannitol on blood coagulation have not been investigated. 
In Study V, mannitol alone and in combination with HES 130/0.4 impaired clot propagation and clot strength in 
vitro. This negative effect of mannitol on thromboelastometry tracings was later confirmed in another in vitro 
study by Luostarinen and coworkers,132 who also reported that blood coagulation is disturbed more by mannitol 
than by equiosmolar hypertonic saline.132  Further clinical studies are necessary to investigate any possible 




LIMITATIONS OF THE STUDIES 
 
Study I is retrospective, and thus may be biased. Studies II and III are small clinical studies not designed to reach 
conclusions on the safety profiles of various fluids. Because of their small populations, the studies did not aim to 
detect differences in clinical outcome. The anaesthesiologists were not blinded to treatment group, but the fluid 
administration was guided by specific protocols. In Study III, the anaesthesia was not totally standardized.  
Studies IV and V are in vitro studies, so in vivo conditions, results should be applied cautiously. The in vitro 





In Studies II and III, haemodynamic variables including CO were measured by the Vigileo-FloTrac system 
(version 3.02). Earlier studies measuring CO with the first and second version of the Vigileo-FloTrac system 
showed poor agreement in low systemic vascular resistance states such as during high-dose vasopressor 
therapy.36, 133 Compared to previous versions, the new third-generation system has improved.134 Acute changes in 
peripheral vascular resistance may, however, reduce reliability in measuring CO accurately.135   We included 
only elective neurosurgical patients, and the doses of vasopressor therapy were low; the risk of altered vascular 
resistance state should thus be minimal. No difference in vasopressor therapy doses between groups occurred. 
Because haemodynamic measurements may be influenced by differences in body surface area formulas in 
morbidly obese patients,136 we excluded such patients.    
 
In Studies II to V, modified thromboelastometry coagulation analysis (ROTEM®) was performed.  Age, gender, 
and oral contraception may influence the parameters determined by ROTEM®.118 In our studies, no patient was 
on oral contraception, and age distributions between groups were comparable. Distribution by gender differed 









The aim of the study was to examine the effects and possible side-effects of fluid therapy that comprised goal-
directed therapy with a crystalloid or a colloid in patients undergoing neurosurgery in the sitting and prone 
positions. The results showed that most of the patients undergoing neurosurgery in the sitting and prone position 
could be managed with an acceptable volume of RAC. 
 
The sitting position is associated with risk for hypotension and for VAE despite fluid filling. GDT with either 
RAC or HES solutions in combination with vasoactives maintains a stable haemodynamic state during 
neurosurgery in the sitting and prone position. During neurosurgery, HES 130/0.4 had a slightly greater positive 
effect on the haemodynamic parameters than did RAC. In hypovolemic patients requiring instant restoration of 
haemodynamics without excessive fluid load, administration of HES according to the goal-directed principle 
might be justified.  
 
The effect of HES 130/0.4 on coagulation as measured by thromboelastometry indicates the possible decreased 
formation and maximum strength of the fibrin clot. The clinical effect of HES 130/0.4 on coagulation is still 
unclear. Taking into account any safety concerns with regard to coagulopathy, renal failure, and mortality 
associated with HES solutions in other patient groups, any use of HES 130/0.4 in neurosurgical patients should 
be cautious. 
 
Based on in vitro observations, a totally balanced fluid concept does not offer advantages in regard to 
haemostatic mechanisms. Mannitol induces a whole-blood coagulation disorder in vitro, especially in 
combination with HES 130/0.4. The combination of mannitol and HES solutions should be avoided in 


















The sitting position in neurosurgery is associated with risks such as haemodynamic instability and VAE. With 
careful titration of fluid therapy in combination with vasoactives, the haemodynamic changes induced by 
positioning can be minimized. Early recognition of air leakage by careful monitoring and good co-operation 
between the surgical and anaesthesia teams is important in reducing the risk for VAE-related complications. The 
advantages with this position are considerable for craniotomy patients with lesions in the pineal or 
cerebellopontine regions, and the risks can be reduced by an experienced team.  
 
The volume ratio between crystalloid and colloid in these studies was surprisingly low. With SV-directed 
administration of fluids, most patients undergoing neurosurgery in the sitting and prone position can be managed 
with acceptable volumes of RAC, avoiding the possible negative effects on coagulation of HES 130/0.4.  
 
The totally balanced fluid concept offers no advantages regarding coagulation mechanisms, but the 
administration of buffered fluids is associated with less metabolic interference such as by metabolic acidosis and 
hyperchloraemia. The combination of mannitol and HES solutions should be avoided, at least until the 



























IMPLICATIONS FOR FUTURE STUDIES 
  
 
Despite the increasing research efforts of the past years, many issues concerning perioperative fluid therapy 
remain. This thesis attempted to answer some questions about fluid therapy in neurosurgical patients, but further 
questions remain. The effect of fluid therapy on clinical outcome should undergo further evaluation. 
 
The volumes of fluid needed in this study were relatively low. The effects of fluid therapy on plasma colloid 
oncotic pressure and the possible effect on cerebral oedema formation require further study in patients. Based on 
experimental studies, a decrease in plasma colloid oncotic pressure, in addition to decreased plasma osmotic 
pressure, may aggravate cerebral oedema. 
 
The possible negative effects of mannitol on coagulation indicated by in vitro studies require further studies in 
neurosurgical patients. 
 
The monitoring of fluid therapy during neurosurgery should be developed for tissue perfusion monitoring to 
minimize risk of inadequate cerebral blood flow perioperatively. 
 
This study included elective neurosurgical patients. Fluid therapy in subgroups such as traumatic brain-injury 
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